Covac1 phase 2a expanded safety and immunogenicity study of a self-amplifying rna vaccine against sars-cov-2

HIGHLIGHTS

• who: Alex J. Szubert from the cMRC Clinical Trials Unit at UCL, London, UK St George`s Vaccine Institute, Institute for Infection and Immunity, St George`s University of London, UK have published the paper: COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2, in the Journal: (JOURNAL) of 20/08/2020
• what: The authors report the results from the expanded safety cohort who received 1 u03bcg following by 10 u03bcg of the candidate saRNA COVID-19 vaccine, LNP-nCoVsaRNA, approximately 14 weeks apart. The authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.